From theDepartment of Clinical Microbiology, Istanbul University, Istanbul, Turkey
Abstract: (4951 Views)
Tuberculosis remains a major public health problem in both developing and
developed countries. Drug-resistant tuberculosis is an increasing health problem
and serious challenge to tuberculosis (TB) control programs. Information about
the susceptibility pattern of Mycobacterium tuberculosis isolates against anti-tuberculosis
drugs is an important aspect to TB control. The objectives of the study
were to evaluate the frequency of drug-resistance and to survey the nature of drug
resistance among patients with pulmonary tuberculosis.
Ninety-one M. tuberculosis strains were isolated from sputum samples of
patients referred to Cerrhapasa Medical Faculty Hospital, Istanbul, Turkey, during
a 9 month period. Drug susceptibility testing was performed to isoniazid (INH),
streptomycin (SM), ethambutol (EMB) and rifampin (RMP) on Lowenstein-Jensen
medium according to proportion method.
Total resistance was identified in 40 of 91 patients (44%). The highest rate of
primary resistance was to SM (21.1 %), followed by INH (15.8%), RMP (5.3%)
and EMB (2.6%). Secondary resistance was most frequent to INH (33.3%), followed
by SM (28.6%), RMP (23.8%) and EMB (14.3%). Multidrug resistance
(MDR) was observed in 6 of the 91 cases (6.6%). Due to the high prevalence of
drug resistance, particularly in developing countries, further studies should be
conducted regularly to monitor resistance in these countries.